Understanding alveolarization to induce lung regeneration

• Published in: Respiratory research Vol. 19; no. 1; p. 148
• Main Authors: Rodríguez-Castillo, José Alberto, Pérez, David Bravo, Ntokou, Aglaia, Seeger, Werner, Morty, Rory E, Ahlbrecht, Katrin
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 06-08-2018; BioMed Central; BMC
• Subjects: Alveolarization; Alveoli; Angiogenesis; Animals; Care and treatment; Cells (biology); Chronic obstructive pulmonary disease; Destruction; Disease; Diseases; Dysplasia; Extracellular matrix; Fibroblasts; Fibrosis; Gas exchange; Gene expression; Growth factors; Humans; Kinases; Lung - pathology; Lung - physiology; Lung diseases; Lung Injury - metabolism; Lung Injury - pathology; Lung Injury - physiopathology; Lungs; Mesenchyme; Morbidity; Neo-alveolarization; Obstructive lung disease; Organic chemistry; Progenitor cells; Pulmonary Alveoli - pathology; Pulmonary Alveoli - physiology; Pulmonary fibrosis; Quality of life; Regeneration; Regeneration - physiology; Regenerative medicine; Review; Rodents; Septation; Signs and symptoms; Stem cells; Time dependence; Neo-alveolarization; Regeneration; Alveolarization
• ISSN: 1465-993X; 1465-9921; 1465-993X; 1465-9921
• DOI: 10.1186/s12931-018-0837-5

Gas exchange represents the key physiological function of the lung, and is dependent upon proper formation of the delicate alveolar structure. Malformation or destruction of the alveolar gas-exchange regions are key histopathological hallmarks of diseases such as bronchopulmonary dysplasia (BPD), chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis; all of which are characterized by perturbations to the alveolo-capillary barrier structure. Impaired gas-exchange is the primary initial consequence of these perturbations, resulting in severe clinical symptoms, reduced quality of life, and death. The pronounced morbidity and mortality associated with malformation or destruction of alveoli underscores a pressing need for new therapeutic concepts. The re-induction of alveolarization in diseased lungs is a new and exciting concept in a regenerative medicine approach to manage pulmonary diseases that are characterized by an absence of alveoli.
Mechanisms of alveolarization first need to be understood, to identify pathways and mediators that may be exploited to drive the induction of alveolarization in the diseased lung. With this in mind, a variety of candidate cell-types, pathways, and molecular mediators have recently been identified. Using lineage tracing approaches and lung injury models, new progenitor cells for epithelial and mesenchymal cell types - as well as cell lineages which are able to acquire stem cell properties - have been discovered. However, the underlying mechanisms that orchestrate the complex process of lung alveolar septation remain largely unknown.
While important progress has been made, further characterization of the contributing cell-types, the cell type-specific molecular signatures, and the time-dependent chemical and mechanical processes in the developing, adult and diseased lung is needed in order to implement a regenerative therapeutic approach for pulmonary diseases.